LIMINATUS PHARMA, INC. Earnings Per Share (Basic)
LIMINATUS PHARMA, INC. (LIMN) reported Earnings Per Share (Basic) of -$0.03 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- LIMINATUS PHARMA, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.03.
- LIMINATUS PHARMA, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.03.
- LIMINATUS PHARMA, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07.
- LIMINATUS PHARMA, INC. earnings per share, basic for the quarter ending 2025-06-30 was $0.00.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.03 10-Q · filed 2026-08-14 | -$0.06 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$0.03 S-1 · filed 2026-06-24 | ||||
| 2025-12-31 | -$0.43 S-1 · filed 2026-06-24 | ||||
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-14 | -$0.09 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | -$0.01 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | -$0.02 S-1 · filed 2026-06-24 | -$2.55 10-Q · filed 2025-06-02 | |||
| 2024-12-31 | -$0.20 S-1 · filed 2026-06-24 | ||||
| 2024-09-30 | -$0.03 10-Q · filed 2025-11-14 | -$0.19 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$0.05 10-Q · filed 2025-10-06 | -$0.16 10-Q · filed 2025-10-06 | |||
| 2024-03-31 | -$2.47 10-Q · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |